MoonLake Stock (NASDAQ: MLTX) stock price, news, charts, stock research, profile.
You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.
Other companies in MoonLake’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Alkermes (NASDAQ:ALKS), SpringWorks Therapeutics (NASDAQ:SWTX) and PTC Therapeutics (NASDAQ:PTCT).
MoonLake has a consensus price target of $64.54.
The stock price for MoonLake (NASDAQ: MLTX) is $54.1716 last updated November 25, 2024 at 4:01 PM EST.
There are no upcoming dividends for MoonLake.
MoonLake’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for MoonLake.
MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.